Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery
Ji Young Yhee, Jintaek Im, Richard Nho
Journal of Clinical Medicine (2016) Vol. 5, Iss. 9, pp. 82-82
Open Access | Times Cited: 108

Showing 26-50 of 108 citing articles:

In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
Kun Huang, Daniel Zapata, Yan Tang, et al.
Biomaterials (2022) Vol. 291, pp. 121876-121876
Open Access | Times Cited: 33
Nanoparticle transport and deposition in a heterogeneous human lung airway tree: An efficient one path model for CFD simulations
Md Mostafizur Rahman, Ming Zhao, Mohammad S. Islam, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 177, pp. 106279-106279
Open Access | Times Cited: 30
Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies
Elena Fernández Fernández, Beatriz Santos-Carballal, Chiara De Santi, et al.
Materials (2018) Vol. 11, Iss. 1, pp. 122-122
Open Access | Times Cited: 51
Future Trends in Nebulized Therapies for Pulmonary Disease
S. McCarthy, H. Esteban, Brendan D. Higgins
Journal of Personalized Medicine (2020) Vol. 10, Iss. 2, pp. 37-37
Open Access | Times Cited: 49
Effect of Poly(vinyl alcohol) on Nanoencapsulation of Budesonide in Chitosan Nanoparticles via Ionic Gelation and Its Improved Bioavailability
Georgia Michailidou, Nina Maria Ainali, Eleftheria Xanthopoulou, et al.
Polymers (2020) Vol. 12, Iss. 5, pp. 1101-1101
Open Access | Times Cited: 48
<p>Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases</p>
Mehak Passi, Sadia Shahid, S. Chockalingam, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 3803-3826
Open Access | Times Cited: 39
Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases
Md Sadique Hussain, Parvarish Sharma, Daljeet Singh Dhanjal, et al.
Chemico-Biological Interactions (2021) Vol. 348, pp. 109637-109637
Open Access | Times Cited: 39
Nanobiosystems-based chronotherapeutics in treatment of asthma
Mahendra Patel, Arpna Indurkhya, Arun M Prajapati, et al.
Elsevier eBooks (2025), pp. 117-153
Closed Access
Development of biodegradable polymeric nanoparticles–based nanobiosystems
Y.K. Tyagi, Rajesh Kumar, Arun Sharma
Elsevier eBooks (2025), pp. 241-302
Closed Access
Current advances in nanocarriers for biomedical research and their applications
Rout George Kerry, Han‐Seung Shin, Sushanto Gouda, et al.
Artificial Cells Nanomedicine and Biotechnology (2018) Vol. 46, Iss. sup2, pp. 1053-1062
Open Access | Times Cited: 41
Design and characterization of emulsified spray dried alginate microparticles as a carrier for the dually acting drug roflumilast
Azza A. Mahmoud, Nermeen A. Elkasabgy, Abdelfattah A. Abdelkhalek
European Journal of Pharmaceutical Sciences (2018) Vol. 122, pp. 64-76
Closed Access | Times Cited: 38
Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer
Gokce Alp, Nihal Aydoğan
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 149, pp. 45-57
Closed Access | Times Cited: 37
Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases
Yinghan Chan, Venkata Sita Rama Raju Allam, Keshav Raj Paudel, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 19, pp. 3302-3332
Closed Access | Times Cited: 28
Interactions of Nanoparticles with Macrophages and Feasibility of Drug Delivery for Asthma
Sung Hun Kang, Yoo Seob Shin, Dong-Hyun Lee, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1622-1622
Open Access | Times Cited: 20
Role of STING in the treatment of non-small cell lung cancer
Wenhua Tang, Wenjie Zhou, Mei Ji, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
A review on micro and nanoengineering in Powder-Based pulmonary drug delivery
L. Paséro, Francesca Susa, Tania Limongi, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124248-124248
Open Access | Times Cited: 4
Mechanisms of Bleomycin-induced Lung Fibrosis: A Review of Therapeutic Targets and Approaches
Shaimaa M. Mohammed, Haider Falih Shamikh Al-Saedi, Amjed Qasim Mohammed, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1845-1870
Closed Access | Times Cited: 4
Advancements in nanostructured lipid carriers as drug delivery vehicles in the lungs
Babar Iqbal, Kashish Aziz, Nasiruddin Ahmad Farooqui, et al.
Elsevier eBooks (2025), pp. 105-120
Closed Access
Feasibility Study of Mesoporous Silica Particles for Pulmonary Drug Delivery: Therapeutic Treatment with Dexamethasone in a Mouse Model of Airway Inflammation
Tina Gulin-Sarfraz, Sofia Jonasson, Elisabeth Wigenstam, et al.
Pharmaceutics (2019) Vol. 11, Iss. 4, pp. 149-149
Open Access | Times Cited: 35
Advancing Treatment Strategies: A Comprehensive Review of Drug Delivery Innovations for Chronic Inflammatory Respiratory Diseases
Junming Wang, Pengfei Wang, Yiru Shao, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2151-2151
Open Access | Times Cited: 9
Lipid mediators of inhalation exposure-induced pulmonary toxicity and inflammation
Arjun Pitchai, Kimberly K. Buhman, Jonathan H. Shannahan
Inhalation Toxicology (2024) Vol. 36, Iss. 2, pp. 57-74
Closed Access | Times Cited: 3
Pulmonary Nano-Drug Delivery Systems for Lung Cancer: Current Knowledge and Prospects
Madumani Amararathna, Kerry B. Goralski, David W. Hoskin, et al.
Journal of Lung Health and Diseases (2019) Vol. 3, Iss. 2, pp. 11-28
Open Access | Times Cited: 27
Toxicity of nanoparticles
Cristina Buzea, Ivan Pacheco
Elsevier eBooks (2019), pp. 705-754
Closed Access | Times Cited: 27
Dry powder formulation for pulmonary infections: Ciprofloxacin loaded in chitosan sub-micron particles generated by electrospray
Beatriz Arauzo, M. Pilar Lobera, A. Μοnzόn, et al.
Carbohydrate Polymers (2021) Vol. 273, pp. 118543-118543
Open Access | Times Cited: 22
Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects
Nisha Gulati, Dinesh Kumar Chellappan, Ronan MacLoughlin, et al.
Life Sciences (2021) Vol. 285, pp. 119969-119969
Closed Access | Times Cited: 22

Scroll to top